This inventor holds 1 USPTO granted patent. Top assignee: Syneurx International (Taiwan) Corp.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Weiju Chang: Innovator in Central Nervous System Treatments
Introduction: Weiju Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of central nervous system disorders. His innovative approach has led to the development of a unique method that utilizes lithium benzoate for therapeutic purposes.
Latest Patents: Weiju Chang holds a patent for the "Use of lithium benzoate for treating central nervous system disorders." This patent outlines methods for treating central nervous system (CNS) disorders or attenuating pain with a lithium benzoate compound. His work in this area has the potential to improve the quality of life for many individuals suffering from these conditions.
Career Highlights: Chang is currently associated with Syneurx International (Taiwan) Corp., where he continues to advance his research and development efforts. His dedication to innovation in the medical field has positioned him as a key figure in the industry.
Collaborations: Throughout his career, Weiju Chang has collaborated with esteemed colleagues, including Guochuan Emil Tsai and Hong-Jung Chen. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion: Weiju Chang's contributions to the treatment of central nervous system disorders through his innovative use of lithium benzoate exemplify the impact of dedicated inventors in the medical field. His work continues to inspire advancements in therapeutic methods and improve patient outcomes.